Susquehanna International Group, LLP Incyte Corp Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Incyte Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 108,634 shares of INCY stock, worth $7.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,634

Previous 190,680 43.03%

Holding current value

$7.39 Million

Previous $10.9 Million 39.38%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$51.18 - $63.75 $4.2 Million - $5.23 Million	-82,046 Reduced 43.03%	108,634 $6.59 Million
Q1 2024 May 07, 2024	BUY	$56.55 - $66.59 $6.77 Million - $7.97 Million	119,639 Added 168.41%	190,680 $10.9 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $1.68 Million - $2.06 Million	-32,118 Reduced 31.13%	71,041 $4.46 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $338,070 - $385,822	5,852 Added 6.01%	103,159 $5.96 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $1.57 Million - $1.95 Million	-25,773 Reduced 20.94%	97,307 $6.06 Million
Q1 2023 May 16, 2023	BUY	$70.23 - $86.01 $3.16 Million - $3.87 Million	44,996 Added 57.63%	123,080 $8.89 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $7.92 Million - $9.92 Million	-117,915 Reduced 60.16%	78,084 $6.27 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $9.84 Million - $12.3 Million	148,637 Added 313.83%	195,999 $13.1 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $2.67 Million - $3.36 Million	-40,339 Reduced 46.0%	47,362 $3.6 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $11.7 Million - $14.1 Million	-177,223 Reduced 66.9%	87,701 $6.97 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $5.31 Million - $6.21 Million	83,814 Added 46.28%	264,924 $19.4 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $2.33 Million - $2.85 Million	33,893 Added 23.02%	181,110 $12.5 Million
Q2 2021 Aug 11, 2021	BUY	$79.87 - $87.53 $1.31 Million - $1.43 Million	16,375 Added 12.52%	147,217 $12.4 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $4.24 Million - $5.6 Million	55,738 Added 74.21%	130,842 $10.6 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $4.27 Million - $5.16 Million	52,830 Added 237.18%	75,104 $6.53 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $7.48 Million - $9.65 Million	-87,930 Reduced 79.79%	22,274 $2 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $796,619 - $1.17 Million	-10,739 Reduced 8.88%	110,204 $11.5 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.17 Million - $1.59 Million	-18,469 Reduced 13.25%	120,943 $8.86 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $3.6 Million - $4.72 Million	-49,272 Reduced 26.11%	139,412 $12.2 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $158,456 - $188,267	2,176 Added 1.17%	188,684 $14 Million
Q2 2019 Aug 16, 2019	BUY	$73.52 - $88.7 $2.44 Million - $2.94 Million	33,157 Added 21.62%	186,508 $15.8 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $11.1 Million - $13.4 Million	150,597 Added 5468.3%	153,351 $13 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $7.58 Million - $10.5 Million	-119,183 Reduced 97.74%	2,754 $237,000
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $878,494 - $1.05 Million	-15,017 Reduced 10.96%	121,937 $7.75 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $67,307 - $80,910	1,090 Added 0.8%	136,954 $9.46 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $2.67 Million - $3.69 Million	43,922 Added 47.77%	135,864 $9.1 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $1.37 Million - $1.67 Million	16,491 Added 21.86%	91,942 $7.66 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $7.06 Million - $8.8 Million	75,451	75,451 $7.15 Million

Others Institutions Holding INCY

# of Institutions

629

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Incyte Corp Transaction History